Xenetic Biosciences, Inc.
XBIO· Nasdaq
XBIOXenetic Biosciences, Inc.
Filed Aug 14, 2014 · 10-Q · 45 days after period end · 0001193125-14-310331
| Metric | Q2 2014 | Q2 2013 |
|---|---|---|
| Revenue | — | $1.00M |
| Net Income | -$2.76M | -$938.33K |
| EPS Diluted | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 14, 2014 · 45 d after period end
